396 results on '"Warrick, Joshua"'
Search Results
2. International Society of Urological Pathology Consensus Conference on Current Issues in Bladder Cancer. Working Group 4: Molecular Subtypes of Bladder Cancer—Principles of Classification and Emerging Clinical Utility
3. Molecular Subtypes of Bladder Cancer: Component Signatures and Potential Value in Clinical Decision-making
4. Relationship Between Availability of Urologists and Primary Care Providers and Stage of Diagnosis for Invasive Urinary Bladder Cancer
5. International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer. Working Group 2: Grading of Mixed Grade, Invasive Urothelial Carcinoma Including Histologic Subtypes and Divergent Differentiations, and Non-Urothelial Carcinomas
6. Urothelium-Specific Expression of Mutationally Activated Pik3ca Initiates Early Lesions of Noninvasive Bladder Cancer
7. Clinical and pathological characteristics of metastatic tumors to the urinary bladder
8. International Society of Urological Pathology Consensus Conference on Current Issues in Bladder Cancer. Working Group 4: Molecular Subtypes of Bladder Cancer—Principles of Classification and Emerging Clinical Utility
9. Management Options for Node-Positive Muscle-Invasive Bladder Cancer.
10. Avelumab in Combination with Eribulin Mesylate in Metastatic Urothelial Carcinoma: BTCRC GU-051, a Phase 1b Study
11. A transcriptional network of cell cycle dysregulation in noninvasive papillary urothelial carcinoma
12. Author Correction: FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation
13. FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation
14. Molekularpathologie bei urologischen Tumoren: Empfehlungen der Konsenskonferenz der Internationalen Gesellschaft für Uropathologie (ISUP) 2019
15. Molecular Pathology of Genitourinary Cancers: Translating the Cancer Genome to the Clinic
16. Context-dependent activation of SIRT3 is necessary for anchorage-independent survival and metastasis of ovarian cancer cells
17. Hypermethylation of FOXA1 and allelic loss of PTEN drive squamous differentiation and promote heterogeneity in bladder cancer
18. Prostate Cancer Molecular Prognosis
19. Prostate Cancer Tissue Diagnosis
20. Upper Urinary Tract Carcinoma In Situ
21. Subtype-associated epigenomic landscape and 3D genome structure in bladder cancer
22. An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
23. Report From the International Society of Urological Pathology (ISUP) Consultation Conference On Molecular Pathology Of Urogenital Cancers. II. Molecular Pathology of Bladder Cancer: Progress and Challenges
24. Acute Invasive Fungal Rhinosinusitis: Frozen Section Histomorphology and Diagnosis with PAS Stain
25. Molecular characterization of tumors meeting diagnostic criteria for the non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)
26. Clinical significance of prominent retraction clefts in invasive urothelial carcinoma
27. Evaluation of PD-L1 and other immune markers in bladder urothelial carcinoma stratified by histologic variants and molecular subtypes
28. Molecular Pathology of Genitourinary Cancers: Translating the Cancer Genome to the Clinic
29. Urothelium-specific expression of mutationally activated Pik3ca initiates early lesions of non-invasive bladder cancer
30. Figure S3 from p120-Catenin Downregulation and PIK3CA Mutations Cooperate to Induce Invasion through MMP1 in HNSCC
31. Table S1 from p120-Catenin Downregulation and PIK3CA Mutations Cooperate to Induce Invasion through MMP1 in HNSCC
32. Mutational status of IDH1 in uveal melanoma
33. Thyroid Cancer Overdiagnosis and Malpractice Climate
34. Molecular Pathology of Genitourinary Cancers: Translating the Cancer Genome to the Clinic
35. Maintenance of the bladder cancer precursor urothelial hyperplasia requires FOXA1 and persistent expression of oncogenic HRAS
36. Repression of transcription factor AP-2 alpha by PPARγ reveals a novel transcriptional circuit in basal-squamous bladder cancer
37. Data from Genetic Variants Implicate Dual Oxidase-2 in Familial and Sporadic Nonmedullary Thyroid Cancer
38. Supplementary Table S2 from Genetic Variants Implicate Dual Oxidase-2 in Familial and Sporadic Nonmedullary Thyroid Cancer
39. Supplementary Methods from Genetic Variants Implicate Dual Oxidase-2 in Familial and Sporadic Nonmedullary Thyroid Cancer
40. AACC Guidance Document on Cervical Cancer Detection: Screening, Surveillance, and Diagnosis
41. Concurrent durvalumab and radiation therapy (DUART) followed by adjuvant durvalumab in patients with localized urothelial cancer of bladder: results from phase II study, BTCRC-GU15-023
42. Defining the clinical characteristics of mammary analog secretory carcinoma of the salivary gland: Analysis of the National Cancer Database
43. FOXA1 and CK14 as markers of luminal and basal subtypes in histologic variants of bladder cancer and their associated conventional urothelial carcinoma
44. Histologic Analysis of Buccal Graft Quality Stratified by Tobacco Use in Patients Undergoing Substitution Urethroplasty
45. Role of MIF1 / MIF2 / CD74 interactions in bladder cancer
46. Papillary renal cell carcinoma revisited: a comprehensive histomorphologic study with outcome correlations
47. Evaluation of tissue PCA3 expression in prostate cancer by RNA in situ hybridization—a correlative study with urine PCA3 and TMPRSS2-ERG
48. Fibroepithelial Stromal Polyp of the Vulva: Case Report and Review of Potential Histologic Mimickers
49. Prostate Cancer Molecular Prognosis
50. Prostate Cancer Tissue Diagnosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.